(0.39%) 5 111.25 points
(0.78%) 38 682 points
(0.66%) 17 766 points
(0.23%) $79.13
(-0.39%) $2.03
(-0.06%) $2 308.20
(-0.24%) $26.77
(1.07%) $972.90
(-0.18%) $0.931
(-0.74%) $10.91
(-0.17%) $0.797
(0.54%) $91.62
Live Chart Being Loaded With Signals
C4X Discovery Holdings plc operates as a drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality...
Stats | |
---|---|
今日成交量 | 27.55M |
平均成交量 | 1.13M |
市值 | 30.27M |
EPS | £0 ( 2024-04-23 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | 3.00 |
ATR14 | £1.896 (15.80%) |
音量 相关性
C4X Discovery Holdings 相关性
10 最正相关 | |
---|---|
NVT.L | 0.95 |
MCL.L | 0.942 |
MAST.L | 0.942 |
ORCA.L | 0.939 |
ETX.L | 0.938 |
GRL.L | 0.936 |
MOTR.L | 0.933 |
CCZ.L | 0.931 |
AVO.L | 0.928 |
MIRI.L | 0.928 |
10 最负相关 | |
---|---|
BILN.L | -0.946 |
JPSA.L | -0.924 |
JGSA.L | -0.917 |
MPO.L | -0.915 |
FEDF.L | -0.913 |
TFRN.L | -0.912 |
XFFE.L | -0.912 |
DEMR.L | -0.904 |
K3C.L | -0.901 |
MAFL.L | -0.894 |
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
C4X Discovery Holdings 相关性 - 货币/商品
C4X Discovery Holdings 财务报表
Annual | 2023 |
营收: | £1.71M |
毛利润: | £1.67M (97.78 %) |
EPS: | £-0.0442 |
FY | 2023 |
营收: | £1.71M |
毛利润: | £1.67M (97.78 %) |
EPS: | £-0.0442 |
FY | 2022 |
营收: | £2.70M |
毛利润: | £2.57M (95.18 %) |
EPS: | £-0.0357 |
FY | 2021 |
营收: | £5.64M |
毛利润: | £5.55M (98.40 %) |
EPS: | £-0.0400 |
Financial Reports:
No articles found.
C4X Discovery Holdings
C4X Discovery Holdings plc operates as a drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality. The company's product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation and autoimmune diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. It has partnerships with Sanofi, GEN-COVID, LifeArc, Indivior PLC, Phoremost, AstraZeneca UK Limited, and Evotec SE. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。